Take a few minutes to read this Investor’s Business Daily Commentary: A Sick Calculation About Prescription Drugs http://bit.ly/2gfvdvJ
International Academy of Compounding Pharmacists (IACP) Opinion: As America’s Pharmacy Benefit Management (PBM) industry consolidates, size and scale was supposed to reduce costs to patients, taxpayers and employers. Now, with just three PBMs dominating more than 70% of all prescription reimbursement, the promised benefits are increasingly suspect. Instead, near monopoly control of the landscape and a truly opaque business model has reaped PBM’s record profits. Meanwhile, pharmacies, prescribers, employers and patients are beleaguered a myriad of ways due to unchecked PBM actions.
The IACP Reimbursement & Insurance Committee is monitoring the activities of PBMs and working with industry partners to shine light on PBM activities. Gradually, eyes are opening in Washington D.C., and at America’s employers. If you have a story or experience of PBM abuses, contact us at firstname.lastname@example.org.